Not Yet Recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial NCT07576725 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more Locations Uganda Cancer Institute — Kampala, Uganda View Trial Details
Active, Not Recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer NCT05122546 Conditions Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, +26 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
Active, Not Recruiting Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy NCT04645680 Conditions Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Eye Diseases, +23 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
